All In Biotech

Free tool

FAERS Monitor: Zusduri

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215793 or its brand name (Zusduri, Mitomycin). Reports on generic versions are filed under their own applications.

Reports

2,955

Serious

2,453

83% of reports

Hospitalization

888

Death reported

379

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use364
  • diarrhoea152
  • nausea138
  • dysuria112
  • drug ineffective108
  • thrombocytopenia107
  • neutropenia106
  • disease progression98
  • pancytopenia93
  • vomiting90
  • fatigue89
  • inappropriate schedule of product administration89
  • rash83
  • therapy interrupted80
  • death77

Reports by year received

View as table
YearReports
200467
200577
200686
200796
2008125
200979
201094
2011137
2012134
2013129
201486
2015112
201697
201786
2018127
2019160
2020152
2021126
202289
202374
2024132
2025212
2026478

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,204 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dysuriaSignal11221.718.12,190
pancytopeniaSignal9311.99.7915
therapy interruptedSignal808.06.4482
thrombocytopeniaSignal1076.85.7528
disease progressionSignal985.94.9396
neutropeniaSignal1065.64.6393
inappropriate schedule of product administrationSignal893.52.9159
off label useSignal3643.02.7491
diarrhoea1521.71.442
vomiting901.41.19
rash831.41.18
nausea1381.21.16
fatigue890.80.74
death770.60.516
drug ineffective1080.60.534

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.